The analysts forecast the Regenerative Medicine Market in the US to grow at a CAGR of 23.53% during the period 2017-2021.

New York, NY -- (SBWire) -- 08/21/2018 --US Regenerative Medicine Market

WiseGuyRerports.com Presents "Regenerative Medicine Market in the US 2017-2021" New Document to its Studies Database. The Report Contain 107 Pages With Detailed Analysis.

Description

Regenerative medicine is a bioproduct, which is developed by using translational research techniques such as molecular biology, tissue engineering, and gene engineering. Stem cells and tissue scaffolds have the effective therapeutic potential, which has increased the adoption of regenerative medicine in the US market. Stem cell therapy responds well to various treatments such as dermatological, macular, musculoskeletal, and cardiovascular applications. The regenerative medicine industry includes four key sectors, which help the vendors to develop regenerative medicine.

The analysts forecast the Regenerative Medicine Market in the US to grow at a CAGR of 23.53% during the period 2017-2021.

Covered in this report 
The report covers the present scenario and the growth prospects of the Regenerative Medicine Market in the US for 2017-2021. To calculate the market size, the report considers the sales, volume, and value of regenerative medicine market in the US.

 

Get sample Report @ https://www.wiseguyreports.com/sample-request/1651674-regenerative-medicine-market-in-the-us-2017-2021

 

The Regenerative Medicine Market in the US 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors 
- Acelity 
- Medtronic 
- MiMedx 
- Organogenesis 
- Zimmer Biomet 

Other prominent vendors 
- ACE Surgical Supply 
- Acera Surgical 
- Acologix 
- Advanced Biologics 
- AlloCure 
- AlloSource 
- Alphatec Spine 
- ANTEROGEN 
- Antibe Therapeutics 
- Astellas Pharma 
- Athersys 
- Avita Medical 
- AxoGen 
- Bacterin International 
- Baxter 
- Bellicum Pharmaceuticals 
- BioCardia 
- Biogen 
- BioRestorative Therapies 
- Biostage 
- Bio-Tissue 
- BioTissue 
- bluebird bio 
- BONESUPPORT 
- BrainStorm Cell Therapeutics 
- Caladrius 
- Calimmune 
- Capricor Therapeutics 
- CELGENE 
- Cell Medica 
- Cell Therapy 
- CellBioMed 
- CellSeed 
- Celyad 
- CESCA THERAPEUTICS 
- CTM CRC 
- CryoLife 
- Cynata 

Market driver 
- CVD and diabetes in young adult and aging population 
- For a full, detailed list, view our report

Market challenge 
- High cost of clinical trial 
- For a full, detailed list, view our report

Market trend 
- Increasing strategic alliances 
- For a full, detailed list, view our report

Key questions answered in this report 
- What will the market size be in 2021 and what will the growth rate be? 
- What are the key market trends? 
- What is driving this market? 
- What are the challenges to market growth? 
- Who are the key vendors in this market space? 
- What are the market opportunities and threats faced by the key vendors? 
- What are the strengths and weaknesses of the key vendors?

 

Complete Report Details @ https://www.wiseguyreports.com/reports/1651674-regenerative-medicine-market-in-the-us-2017-2021

 

Table of Contents -Major Key Points

PART 01: Executive summary 

PART 02: Scope of the report 

PART 03: Research Methodology 

PART 04: Introduction 
- Overview of regenerative medicine in the US market 

PART 05: Market landscape 
- Market overview 
- Market size and forecast 

PART 06: Pipeline portfolio 
- Five forces analysis 

PART 07: Market segmentation by product 
- Cell therapy market in US 
- Tissue scaffolds market in US 

PART 08: Market segmentation by application 
- Dermatological 
- Musculoskeletal 
- Ocular 
- Cardiovascular 

PART 09: Market segmentation by end-user 
- Hospitals 
- ASCs 
- Regenerative medicine centers 

PART 10: Decision framework 

PART 11: Drivers and challenges 
- Market drivers 
- Market challenges 

PART 12: Market trends 
- Increasing strategic alliances 
- Increasing number of regenerative medicine in product line 
- Gene therapy trending toward market expansion 

PART 13: Vendor landscape 
- Competitive landscape 

PART 14: Key vendor analysis 
- Acelity 
- Medtronic 
- MiMedx Group 
- Organogenesis 
- Zimmer Biomet 
- Other prominent vendors 

……..CONTINUED